GE invests $5 million in heart disease test maker

AP/ABC News, May 14, 2010

General Electric Co.'s healthcare unit has announced a partnership with CardioDx, which develops genetic tests that are used in diagnosing heart disease. GE Healthcare, which makes diagnostic and medical imaging products, said it invested $5 million in CardioDx through an equity fund that invests in healthcare technology companies. CardioDx makes genetic tests that can be used in treatment of people with conditions including heart failure and coronary artery disease.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.